ConductScience.org, home
Papers
API referenceFor AI assistants

Paper · 34830853

Advantages and Challenges of Using ctDNA NGS to Assess the Presence of Minimal Residual Disease (MRD) in Solid Tumors.

Larribère L and 1 other. Cancers (Basel), 2021. Cited by 56 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Advantages and Challenges of Using ctDNA NGS to Assess the Presence of Minimal Residual Disease (MRD) in Solid Tumors. Papers, record 34830853. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34830853

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Advantages and Challenges of Using ctDNA NGS to Assess the Presence of Minimal Residual Disease (MRD) in Solid Tumors.
PubMed
Journal
Cancers (Basel)
PubMed
Year
2021
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
56
iCite
Relative citation ratio, by iCite
2.75
iCite
Revised in PubMed
2024-04-04
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Larribère LLionel
2Martens UMUwe M

Source PubMed

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
NADieter Schwarz FoundationPubMed

Source PubMed

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References78

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
128,368,441Concordance of blood- and tumor-based detection of RAS mutations to guide anti-EGFR therapy in metastatic colorectal cancer.Ann Oncol2017https://conductscience.org/library/papers/28368441PubMed
233,926,918Minimal Residual Disease Detection using a Plasma-only Circulating Tumor DNA Assay in Patients with Colorectal Cancer.Clin Cancer Res2021https://conductscience.org/library/papers/33926918PubMed
328,950,295RAS testing of liquid biopsy correlates with the outcome of metastatic colorectal cancer patients treated with first-line FOLFIRI plus cetuximab in the CAPRI-GOIM trial.Ann Oncol2018https://conductscience.org/library/papers/28950295PubMed
430,395,155Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic.Ann Oncol2019https://conductscience.org/library/papers/30395155PubMed
533,020,649Clinical utility of circulating tumor DNA sequencing in advanced gastrointestinal cancer: SCRUM-Japan GI-SCREEN and GOZILA studies.Nat Med2020https://conductscience.org/library/papers/33020649PubMed
611,861,434Predominant hematopoietic origin of cell-free DNA in plasma and serum after sex-mismatched bone marrow transplantation.Clin Chem2002https://conductscience.org/library/papers/11861434PubMed
731,383,735Validation of Microsatellite Instability Detection Using a Comprehensive Plasma-Based Genotyping Panel.Clin Cancer Res2019https://conductscience.org/library/papers/31383735PubMed
828,899,864Early Detection of Molecular Residual Disease in Localized Lung Cancer by Circulating Tumor DNA Profiling.Cancer Discov2017https://conductscience.org/library/papers/28899864PubMed
934,327,297Detection of Molecular Residual Disease Using Personalized Circulating Tumor DNA Assay in Patients With Colorectal Cancer Undergoing Resection of Metastases.JCO Precis Oncol2021https://conductscience.org/library/papers/34327297PubMed
1031,711,920Circulating Tumor DNA Analysis for Detection of Minimal Residual Disease After Chemoradiotherapy for Localized Esophageal Cancer.Gastroenterology2020https://conductscience.org/library/papers/31711920PubMed

1 to 10 of 78

See all 78 references

Cited by46

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 56 citations.

PMIDTitleJournalYearIn PapersSource
42,699,009Circulating Tumor DNA in Breast Cancer: A Liquid Biopsy Revolution for Non-Invasive Genomic Profiling and Clinical Decision-Making.Breast Cancer (Auckl)2026https://conductscience.org/library/papers/42699009PubMed
42,524,535The Role of Precision Medicine in Neuroblastoma: Targeted Therapies and Personalized Approaches-A Narrative Review.Health Sci Rep2026https://conductscience.org/library/papers/42524535PubMed
42,508,231Common analysis pitfalls in longitudinal ctDNA studies: lead time, sensitivity and immortal time bias.EBioMedicine2026https://conductscience.org/library/papers/42508231PubMed
42,279,362Advances in Brain Tumor Biomarkers: From Molecular Profiling to Liquid Biopsy and AI-Driven Detection.Cancers (Basel)2026https://conductscience.org/library/papers/42279362PubMed
42,079,635Research progress in augmentation strategies for PD-1/PD-L1 inhibitors in bladder cancer: from biological determinants to clinical applications.Front Immunol2026https://conductscience.org/library/papers/42079635PubMed
41,912,863Circulating tumor DNA-based detection of molecular residual disease in isocitrate dehydrogenase-mutant cholangiocarcinoma for biomarker-guided therapy.Clin Transl Oncol2026https://conductscience.org/library/papers/41912863PubMed
41,827,748Circulating Tumour DNA After Neoadjuvant Therapy in Non-Metastatic Colon Cancer: A Systematic Review and Implications for Surgical Decision-Making.Cancers (Basel)2026https://conductscience.org/library/papers/41827748PubMed
41,816,119From imaging to omics: deep learning is bridging MRI and liquid biopsy in bone tumor diagnosis.J Bone Oncol2026https://conductscience.org/library/papers/41816119PubMed
41,611,911Circulating tumor DNA dynamics predict pathological response and guide therapy personalization in the neoadjuvant setting.Discov Oncol2026https://conductscience.org/library/papers/41611911PubMed
41,463,256A Novel Protein Serum Biomarker Assay for Tracking (Neo)adjuvant and Metastatic Therapy Efficacy and Enabling the Timely Detection of Relapse in Breast Cancer.Cancers (Basel)2025https://conductscience.org/library/papers/41463256PubMed

1 to 10 of 46

See all 46 cited by

Genes8

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD27429,126PubTator's text mininghttps://conductscience.org/library/genes/29126NCBI Gene
DNMT3A1,788PubTator's text mininghttps://conductscience.org/library/genes/1788NCBI Gene
EGFR1,956PubTator's text mininghttps://conductscience.org/library/genes/1956NCBI Gene
PDCD15,133PubTator's text mininghttps://conductscience.org/library/genes/5133NCBI Gene
PPM1D8,493PubTator's text mininghttps://conductscience.org/library/genes/8493NCBI Gene
TET254,790PubTator's text mininghttps://conductscience.org/library/genes/54790NCBI Gene
TP537,157PubTator's text mininghttps://conductscience.org/library/genes/7157NCBI Gene
TXK7,294PubTator's text mininghttps://conductscience.org/library/genes/7294NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/34830853

GET https://conductscience.org/api/papers/v1/34830853/references?page=2

API referenceFor AI assistants